GSK will inaugurate its newest global vaccines research and development (R&D) center in Rockville, Maryland, further strengthening and expanding its vaccines presence in the USA. Up to 200 new jobs will be created at the Rockville facility, with GSK investing over $50 million in the next two years to continue to develop the site with latest state-of-the-art scientific research technology and equipment.
{iframe}http://www.gsk.com/en-gb/media/press-releases/2016/gsk-opens-new-global-vaccines-randd-center-in-rockville-md-usa/{/iframe}